Updated Perspectives on the Diagnosis and Management of Neonatal Invasive Candidiasis

References

• Arsenault AB, Bliss JM. Neonatal candidiasis: new insights into an old problem at a unique host-pathogen interface. Curr Fungal Infect Rep. 2015;9(4):246–252. doi:10.1007/s12281-015-0238-x
   PubMedGoogle Scholar
• Rowen JL. Mucocutaneous candidiasis. Semin Perinatol. 2003;27(5):406–413. doi:10.1016/s0146-0005(03)00066-1
   PubMed Web of Science ®Google Scholar
• Benjamin DK, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126(4):e865–73. doi:10.1542/peds.2009-3412
   PubMed Web of Science ®Google Scholar
• Kilpatrick R, Scarrow E, Hornik C, Greenberg RG. Neonatal invasive candidiasis: updates on clinical management and prevention. Lancet Child Adolesc Health. 2022;6(1):60–70. doi:10.1016/s2352-4642(21)00272-8
   PubMedGoogle Scholar
• Filippidi A, Galanakis E, Maraki S, et al. The effect of maternal flora on Candida colonisation in the neonate. Mycoses. 2014;57(1):43–48. doi:10.1111/myc.12100
   PubMed Web of Science ®Google Scholar
• Al-Rusan RM, Darwazeh AMG, Lataifeh IM. The relationship of Candida colonization of the oral and vaginal mucosae of mothers and oral mucosae of their newborns at birth. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(4):459–463. doi:10.1016/j.oooo.2017.01.003
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases Society of America. Clin Infect Dis. 2015;62(4):e1–e50. doi:10.1093/cid/civ933
   PubMedGoogle Scholar
• Kelly MS, Benjamin DK, Smith PB. The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol. 2015;42(1):105–17, viii–ix. doi:10.1016/j.clp.2014.10.008
   Web of Science ®Google Scholar
• Vasileiou E, Apsemidou A, Vyzantiadis TA, Tragiannidis A. Invasive candidiasis and candidemia in pediatric and neonatal patients: a review of current guidelines. Curr Med Mycol. 2018;4(3):28–33. doi:10.18502/cmm.4.3.173
   PubMedGoogle Scholar
• Alvarado-Socarras JL, Vargas-Soler JA, Franco-Paredes C, Villegas-Lamus KC, Rojas-Torres JP, Rodriguez-Morales AJ. A cluster of neonatal infections caused by Candida auris at a large referral center in Colombia. J Pediatric Infect Dis Soc. 2021;10(5):549–555. doi:10.1093/jpids/piaa152
   PubMed Web of Science ®Google Scholar
• Kaur H, Chakrabarti A. Strategies to reduce mortality in adult and neonatal candidemia in developing countries. J Fungi. 2017;3(3):41. doi:10.3390/jof3030041
   Web of Science ®Google Scholar
• Benjamin DK, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117(1):84–92. doi:10.1542/peds.2004-2292
   PubMed Web of Science ®Google Scholar
• Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118(2):717–722. doi:10.1542/peds.2005-2677
   PubMed Web of Science ®Google Scholar
• Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis. 1996;22 Suppl 2(Supplement_2):S73–88. doi:10.1093/clinids/22.supplement_2.s73
   PubMedGoogle Scholar
• Cook A, Ferreras-Antolin L, Adhisivam B, et al. Neonatal invasive candidiasis in low- and middle-income countries: data from the NeoOBS study. Med Mycol. 2023;61(3). doi:10.1093/mmy/myad010
   PubMed Web of Science ®Google Scholar
• Aliaga S, Clark RH, Laughon M, et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics. 2014;133(2):236–242. doi:10.1542/peds.2013-0671
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Invasive Candidiasis statistics; [ updated January 13, 2023]. Available from: https://www.cdc.gov/fungal/diseases/candidiasis/invasive/statistics.html. Accessed September 28, 2023.
   Google Scholar
• Scamardo MS, Dolce P, Esposito EP, Raimondi F, Triassi M, Zarrilli R. Trends, risk factors and outcomes of healthcare-associated infections in a neonatal intensive care unit in Italy during 2013–2017. Ital J Pediatr. 2020;46(1):34. doi:10.1186/s13052-020-0799-3
   PubMed Web of Science ®Google Scholar
• Oeser C, Vergnano S, Naidoo R, et al. Neonatal invasive fungal infection in England 2004–2010. Clin Microbiol Infect. 2014;20(9):936–941. doi:10.1111/1469-0691.12578
   PubMed Web of Science ®Google Scholar
• Ting JY, Roberts A, Synnes A, et al. Invasive fungal infections in neonates in Canada: epidemiology and outcomes. Pediatr Infect Dis J. 2018;37(11):1154–1159. doi:10.1097/inf.0000000000001968
   PubMed Web of Science ®Google Scholar
• Howell A, Isaacs D, Halliday R. Oral nystatin prophylaxis and neonatal fungal infections. Arch Dis Child Fetal Neonatal Ed. 2009;94(6):F429–33. doi:10.1136/adc.2008.157123
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292(19):2357–2365. doi:10.1001/jama.292.19.2357
   PubMed Web of Science ®Google Scholar
• Greenberg RG, Benjamin DK, Gantz MG, et al. Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. J Pediatr. 2012;161(2):264–9.e2. doi:10.1016/j.jpeds.2012.01.053
   PubMed Web of Science ®Google Scholar
• Cahan H, Deville JG. Outcomes of neonatal candidiasis: the impact of delayed initiation of antifungal therapy. Int J Pediatr. 2011;2011:813871. doi:10.1155/2011/813871
   PubMedGoogle Scholar
• Calley JL, Warris A. Recognition and diagnosis of invasive fungal infections in neonates. J Infect. 2017;74(Suppl 1):S108–s113. doi:10.1016/s0163-4453(17)30200-1
   PubMedGoogle Scholar
• Walsh TJ, Katragkou A, Chen T, Salvatore CM, Roilides E. Invasive Candidiasis in infants and children: recent advances in epidemiology, diagnosis, and treatment. J Fungi. 2019;5(1):11. doi:10.3390/jof5010011
   Web of Science ®Google Scholar
• Benjamin DK, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics. 2003;112(3 Pt 1):634–640. doi:10.1542/peds.112.3.634
   PubMed Web of Science ®Google Scholar
• Lingappan A, Wykoff CC, Albini TA, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153(1):162–6.e1. doi:10.1016/j.ajo.2011.06.020
   PubMed Web of Science ®Google Scholar
• Alhamoud MA, Alnosair GH, Alhashim HY. Neonatal endogenous endophthalmitis: a case report. Cureus. 2022;14(2):e22256. doi:10.7759/cureus.22256
   PubMed Web of Science ®Google Scholar
• Ferrando G, Castagnola E. Prophylaxis of invasive fungal infection in neonates: a narrative review for practical purposes. J Fungi. 2023;9(2):164. doi:10.3390/jof9020164
   Web of Science ®Google Scholar
• Goudjil S, Kongolo G, Dusol L, et al. (1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate. J Matern Fetal Neonatal Med. 2013;26(1):44–48. doi:10.3109/14767058.2012.722716
   PubMed Web of Science ®Google Scholar
• Horvath LL, Hospenthal DR, Murray CK, Dooley DP. Detection of simulated candidemia by the BACTEC 9240 system with plus aerobic/F and anaerobic/F blood culture bottles. J Clin Microbiol. 2003;41(10):4714–4717. doi:10.1128/jcm.41.10.4714-4717.2003
   PubMed Web of Science ®Google Scholar
• Horvath LL, George BJ, Murray CK, Harrison LS, Hospenthal DR. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection. J Clin Microbiol. 2004;42(1):115–118. doi:10.1128/jcm.42.1.115-118.2004
   PubMed Web of Science ®Google Scholar
• Telenti A, Roberts GD. Fungal blood cultures. Eur J Clin Microbiol Infect Dis. 1989;8(9):825–831. doi:10.1007/bf02185855
   PubMed Web of Science ®Google Scholar
• McDonald LC, Weinstein MP, Fune J, Mirrett S, Reimer LG, Reller LB. Controlled comparison of BacT/ALERT FAN aerobic medium and BATEC fungal blood culture medium for detection of fungemia. J Clin Microbiol. 2001;39(2):622–624. doi:10.1128/jcm.39.2.622-624.2001
   PubMed Web of Science ®Google Scholar
• Bersani I, Piersigilli F, Goffredo BM, et al. Antifungal drugs for invasive Candida Infections (ICI) in neonates: future perspectives. Front Pediatr. 2019;7:375. doi:10.3389/fped.2019.00375
   PubMed Web of Science ®Google Scholar
• Keighley C, Cooley L, Morris AJ, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J. 2021;51(Suppl 7):89–117. doi:10.1111/imj.15589
   PubMedGoogle Scholar
• Simor AE, Porter V, Mubareka S, et al. Rapid identification of Candida species from positive blood cultures by use of the FilmArray blood culture identification panel. J Clin Microbiol. 2018;56(12). doi:10.1128/JCM.01387-18
   PubMed Web of Science ®Google Scholar
• Schelonka RL, Moser SA. Time to positive culture results in neonatal Candida septicemia. J Pediatr. 2003;142(5):564–565. doi:10.1067/mpd.2003.188
   PubMed Web of Science ®Google Scholar
• Clancy CJ, Nguyen MH. Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013;56(9):1284–1292. doi:10.1093/cid/cit006
   PubMed Web of Science ®Google Scholar
• Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect. 2008;14(4):391–393. doi:10.1111/j.1469-0691.2007.01938.x
   PubMed Web of Science ®Google Scholar
• Lucignano B, Cento V, Agosta M, et al. Effective rapid diagnosis of bacterial and fungal bloodstream infections by T2 magnetic resonance technology in the pediatric population. J Clin Microbiol. 2022;60(10):e0029222. doi:10.1128/jcm.00292-22
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–899. doi:10.1093/cid/ciu959
   PubMed Web of Science ®Google Scholar
• Ramos JT, Villar S, Bouza E, et al. Performance of a quantitative PCR-based assay and Beta-d-glucan detection for diagnosis of invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study). J Clin Microbiol. 2017;55(9):2752–2764. doi:10.1128/JCM.00496-17
   PubMed Web of Science ®Google Scholar
• George BJ, Horvath LL, Hospenthal DR. Effect of inoculum size on detection of Candida growth by the BACTEC 9240 automated blood culture system using aerobic and anaerobic media. J Clin Microbiol. 2005;43(1):433–435. doi:10.1128/jcm.43.1.433-435.2005
   PubMed Web of Science ®Google Scholar
• Cohen-Wolkowiez M, Smith PB, Mangum B, et al. Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. J Perinatol. 2007;27(2):97–100. doi:10.1038/sj.jp.7211628
   PubMed Web of Science ®Google Scholar
• Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis. 1993;17(2):103–109. doi:10.1016/0732-8893(93)90020-8
   PubMed Web of Science ®Google Scholar
• Johnson MD, Lewis RE, Dodds Ashley ES, et al. Core recommendations for antifungal Stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis. 2020;222(Suppl 3):S175–s198. doi:10.1093/infdis/jiaa394
   PubMedGoogle Scholar
• Huber S, Hetzer B, Crazzolara R, Orth-Höller D. The correct blood volume for paediatric blood cultures: a conundrum? Clin Microbiol Infect. 2020;26(2):168–173. doi:10.1016/j.cmi.2019.10.006
   PubMed Web of Science ®Google Scholar
• Sundararajan S. Ideal blood inoculant volume for neonatal sepsis evaluation: an alternative approach. Pediatr Res. 2021;90(5):930–933. doi:10.1038/s41390-021-01720-2
   PubMed Web of Science ®Google Scholar
• Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1–e94. doi:10.1093/cid/ciy381
   PubMed Web of Science ®Google Scholar
• Howie SR. Blood sample volumes in child health research: review of safe limits. Bull World Health Organ. 2011;89(1):46–53. doi:10.2471/blt.10.080010
   PubMed Web of Science ®Google Scholar
• Lancaster DP, Friedman DF, Chiotos K, Sullivan KV, Carroll KC. Blood volume required for detection of low levels and ultralow levels of organisms responsible for neonatal bacteremia by use of Bactec Peds Plus/F, Plus Aerobic/F Medium, and the BD Bactec FX system: an in vitro study. J Clin Microbiol. 2015;53(11):3609–3613. doi:10.1128/jcm.01706-15
   PubMed Web of Science ®Google Scholar
• Harewood FC, Curtis N, Daley AJ, Bryant PA, Gwee A, Connell TG. Adequate or inadequate? The volume of blood submitted for blood culture at a tertiary children’s hospital. Clin Pediatr. 2018;57(11):1310–1317. doi:10.1177/0009922818778042
   PubMed Web of Science ®Google Scholar
• Ruhnke M, Rickerts V, Cornely OA, et al. Diagnosis and therapy of Candida infections: joint recommendations of the German speaking mycological society and the Paul-Ehrlich-Society for chemotherapy. Mycoses. 2011;54(4):279–310. doi:10.1111/j.1439-0507.2011.02040.x
   PubMed Web of Science ®Google Scholar
• Dulanto-Reinoso CM, Martinez-Castellanos MA. Detection of Candida endophthalmitis in a newborn using handheld spectral-domain optical coherence tomography. Case Rep Ophthalmol. 2018;9(3):439–443. doi:10.1159/000493679
   PubMed Web of Science ®Google Scholar
• Zhao D, Qiu G, Luo Z, Zhang Y, Simeoni U. Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants. PLoS One. 2015;10(4):e0123907. doi:10.1371/journal.pone.0123907
   PubMed Web of Science ®Google Scholar
• Manzoni P, Mostert M, Galletto P, et al. Is thrombocytopenia suggestive of organism-specific response in neonatal sepsis? Pediatr Int. 2009;51(2):206–210. doi:10.1111/j.1442-200X.2008.02689.x
   PubMed Web of Science ®Google Scholar
• Guida JD, Kunig AM, Leef KH, McKenzie SE, Paul DA. Platelet count and sepsis in very low birth weight neonates: is there an organism-specific response? Pediatrics. 2003;111(6 Pt 1):1411–1415. doi:10.1542/peds.111.6.1411
   PubMed Web of Science ®Google Scholar
• Benjamin DK, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics. 2003;112(3 Pt 1):543–547. doi:10.1542/peds.112.3.543
   PubMed Web of Science ®Google Scholar
• Makhoul IR, Kassis I, Smolkin T, Tamir A, Sujov P. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics. 2001;107(1):61–66. doi:10.1542/peds.107.1.61
   PubMed Web of Science ®Google Scholar
• Cohen JF, Ouziel A, Matczak S, et al. Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(3):291–298. doi:10.1016/j.cmi.2019.09.010
   PubMed Web of Science ®Google Scholar
• Smith PB, Benjamin DK, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Clin Vaccine Immunol. 2007;14(7):924–925. doi:10.1128/cvi.00025-07
   PubMedGoogle Scholar
• Lamoth F, Cruciani M, Mengoli C, et al. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis. 2012;54(5):633–643. doi:10.1093/cid/cir897
   PubMed Web of Science ®Google Scholar
• Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol. 2003;10(5):882–885. doi:10.1128/cdli.10.5.882-885.2003
   PubMedGoogle Scholar
• Racil Z, Kocmanova I, Lengerova M, et al. Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies--high frequency of false-positive results and their analysis. J Med Microbiol. 2010;59(Pt9):1016–1022. doi:10.1099/jmm.0.019299-0
   PubMedGoogle Scholar
• Prattes J, Schilcher G, Krause R. Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature. Mycoses. 2015;58(1):4–9. doi:10.1111/myc.12267
   PubMed Web of Science ®Google Scholar
• Wheat LJ. Approach to the diagnosis of invasive aspergillosis and candidiasis. Clin Chest Med. 2009;30(2):367–77, viii. doi:10.1016/j.ccm.2009.02.012
   PubMed Web of Science ®Google Scholar
• Cendejas-Bueno E, Falces-Romero I, Laplaza-González M, et al. Candidemia diagnosis with T2 nuclear magnetic resonance in a PICU: a new approach. Pediatr Crit Care Med. 2021;22(2):e109–e114. doi:10.1097/pcc.0000000000002548
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Zacharioudakis IM, Clancy CJ, Nguyen MH, Pappas PG, Warnock DW. Efficacy of T2 magnetic resonance assay in monitoring Candidemia after initiation of antifungal therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) trial. J Clin Microbiol. 2018;56(4). doi:10.1128/JCM.01756-17
   PubMed Web of Science ®Google Scholar
• Clancy CJ, Pappas PG, Vazquez J, et al. Detecting infections rapidly and easily for candidemia trial, part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel. Clin Infect Dis. 2018;66(11):1678–1686. doi:10.1093/cid/cix1095
   PubMed Web of Science ®Google Scholar
• Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol. 2012;50(10):3301–3308. doi:10.1128/jcm.01405-12
   PubMed Web of Science ®Google Scholar
• Sow D, Fall B, Ndiaye M, et al. Usefulness of MALDI-TOF mass spectrometry for routine identification of Candida Species in a resource-poor setting. Mycopathologia. 2015;180(3–4):173–179. doi:10.1007/s11046-015-9905-2
   PubMed Web of Science ®Google Scholar
• Balows A. Manual of clinical microbiology 8th edition: p. R. Murray, E. J. Baron, J. H. Jorgenson, M. A. Pfaller, and R. H. Yolken, eds., ASM Press, 2003, 2113 pages, 2 vol, 2003 + subject & author indices, ISBN: 1-555810255-4, US$ 189.95. Book Reviews. Diagn Microbiol Infect Dis. 2003;47(4):625–626. doi:10.1016/S0732-8893(03)00160-3
   Google Scholar
• Fernandez J, Erstad BL, Petty W, Nix DE. Time to positive culture and identification for Candida blood stream infections. Diagn Microbiol Infect Dis. 2009;64(4):402–407. doi:10.1016/j.diagmicrobio.2009.04.002
   PubMed Web of Science ®Google Scholar
• Spanu T, Posteraro B, Fiori B, et al. Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol. 2012;50(1):176–179. doi:10.1128/jcm.05742-11
   PubMed Web of Science ®Google Scholar
• Huang AM, Newton D, Kunapuli A, et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis. 2013;57(9):1237–1245. doi:10.1093/cid/cit498
   PubMed Web of Science ®Google Scholar
• Harris DM, Hata DJ. Rapid identification of bacteria and Candida using PNA-FISH from blood and peritoneal fluid cultures: a retrospective clinical study. Ann Clin Microbiol Antimicrob. 2013;12(1):2. doi:10.1186/1476-0711-12-2
   PubMedGoogle Scholar
• Klingspor L, Lindbäck E, Ullberg M, Özenci V. Seven years of clinical experience with the Yeast Traffic Light PNA FISH: assay performance and possible implications on antifungal therapy. Mycoses. 2018;61(3):179–185. doi:10.1111/myc.12722
   PubMed Web of Science ®Google Scholar
• Lau A, Halliday C, Chen SC, Playford EG, Stanley K, Sorrell TC. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol. 2010;48(3):811–816. doi:10.1128/jcm.01650-09
   PubMed Web of Science ®Google Scholar
• Aittakorpi A, Kuusela P, Koukila-Kähkölä P, et al. Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based prove-it sepsis assay. J Clin Microbiol. 2012;50(11):3635–3640. doi:10.1128/jcm.01461-12
   PubMed Web of Science ®Google Scholar
• Kidd SE, Chen SC, Meyer W, Halliday CL. A new age in molecular diagnostics for invasive fungal disease: are we ready? Front Microbiol. 2019;10:2903. doi:10.3389/fmicb.2019.02903
   PubMed Web of Science ®Google Scholar
• He B, Yang Q. Updates in laboratory identification of invasive fungal infection in neonates. Microorganisms. 2023;11(4):1001.
   PubMed Web of Science ®Google Scholar
• Yang Q, He B, Chen C, et al. A rapid, visible, and highly sensitive method for recognizing and distinguishing invasive fungal infections via CCP-FRET technology. ACS Infect Dis. 2021;7(10):2816–2825. doi:10.1021/acsinfecdis.1c00393
   PubMed Web of Science ®Google Scholar
• Graff K, Dominguez SR, Messacar K. Metagenomic next-generation sequencing for diagnosis of pediatric meningitis and encephalitis: a review. J Pediatric Infect Dis Soc. 2021;10(Supplement_4):S78–s87. doi:10.1093/jpids/piab067
   PubMedGoogle Scholar
• Okumura T, Horiba K, Tetsuka N, et al. Next-generation sequencing-based detection of Ureaplasma in the gastric fluid of neonates with respiratory distress and chorioamnionitis. J Matern Fetal Neonatal Med. 2023;36(1):2207113. doi:10.1080/14767058.2023.2207113
   PubMed Web of Science ®Google Scholar
• Agudelo-Pérez S, Fernández-Sarmiento J, Rivera León D, Peláez RG. Metagenomics by next-generation sequencing (mNGS) in the etiological characterization of neonatal and pediatric sepsis: a systematic review. Front Pediatr. 2023;11:1011723. doi:10.3389/fped.2023.1011723
   PubMedGoogle Scholar
• Hill JA, Dalai SC, Hong DK, et al. Liquid Biopsy for invasive mold infections in hematopoietic cell transplant recipients with pneumonia through next-generation sequencing of microbial cell-free DNA in plasma. Clin Infect Dis. 2021;73(11):e3876–e3883. doi:10.1093/cid/ciaa1639
   PubMed Web of Science ®Google Scholar
• Heldman MR, Ahmed AA, Liu W, et al. Serial quantitation of plasma microbial cell-free DNA before and after diagnosis of pulmonary invasive mold infections in hematopoietic cell transplant recipients. J Infect Dis. 2023. doi:10.1093/infdis/jiad255
   PubMed Web of Science ®Google Scholar
• Autmizguine J, Guptill JT, Cohen-Wolkowiez M, Benjamin DK, Capparelli EV. Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications. Drugs. 2014;74(8):891–909. doi:10.1007/s40265-014-0227-3
   PubMed Web of Science ®Google Scholar
• Hope WW, Castagnola E, Groll AH, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect. 2012;18(Suppl 7):38–52. doi:10.1111/1469-0691.12040
   PubMed Web of Science ®Google Scholar
• Wade KC, Wu D, Kaufman DA, et al. Population pharmacokinetics of fluconazole in young infants. Antimicrob Agents Chemother. 2008;52(11):4043–4049. doi:10.1128/aac.00569-08
   PubMed Web of Science ®Google Scholar
• Watt K, Benjamin DK, Cohen-Wolkowiez M. Pharmacokinetics of antifungal agents in children. Early Hum Dev. 2011;87(Suppl 1):S61–5. doi:10.1016/j.earlhumdev.2011.01.014
   PubMedGoogle Scholar
• Piper L, Smith PB, Hornik CP, et al. Fluconazole loading dose pharmacokinetics and safety in infants. Pediatr Infect Dis J. 2011;30(5):375–378. doi:10.1097/INF.0b013e318202cbb3
   PubMed Web of Science ®Google Scholar
• Pammi M. Treatment of Candida Infection in Neonates. Post T, editor. UpToDate; 2023.
   Google Scholar
• Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017;45(6):737–779. doi:10.1007/s15010-017-1042-z
   PubMed Web of Science ®Google Scholar
• Clancy CJ, Nguyen MH. Emergence of Candida auris: an international call to arms. Clin Infect Dis. 2017;64(2):141–143. doi:10.1093/cid/ciw696
   PubMed Web of Science ®Google Scholar
• Fairuz S, Nair RS, Billa N. Orally administered amphotericin B nanoformulations: physical properties of nanoparticle carriers on bioavailability and clinical relevance. Pharmaceutics. 2022;14(9):1823. doi:10.3390/pharmaceutics14091823
   PubMed Web of Science ®Google Scholar
• Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother. 2002;46(3):828–833. doi:10.1128/aac.46.3.828-833.2002
   PubMed Web of Science ®Google Scholar
• Baley JE, Meyers C, Kliegman RM, Jacobs MR, Blumer JL. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr. 1990;116(5):791–797. doi:10.1016/s0022-3476(05)82674-5
   PubMed Web of Science ®Google Scholar
• Benson JM, Nahata MC. Pharmacokinetics of amphotericin B in children. Antimicrob Agents Chemother. 1989;33(11):1989–1993. doi:10.1128/aac.33.11.1989
   PubMed Web of Science ®Google Scholar
• Koren G, Lau A, Klein J, et al. Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr. 1988;113(3):559–563. doi:10.1016/s0022-3476(88)80653-x
   PubMed Web of Science ®Google Scholar
• Nath CE, McLachlan AJ, Shaw PJ, Gunning R, Earl JW. Population pharmacokinetics of amphotericin B in children with malignant diseases. Br J Clin Pharmacol. 2001;52(6):671–680. doi:10.1046/j.0306-5251.2001.01496.x
   PubMed Web of Science ®Google Scholar
• Starke JR, Mason EO, Kramer WG, Kaplan SL. Pharmacokinetics of amphotericin B in infants and children. J Infect Dis. 1987;155(4):766–774. doi:10.1093/infdis/155.4.766
   PubMed Web of Science ®Google Scholar
• Lestner JM, Smith PB, Cohen-Wolkowiez M, Benjamin DK, Hope WW. Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective. Br J Clin Pharmacol. 2013;75(6):1381–1395. doi:10.1111/bcp.12025
   PubMed Web of Science ®Google Scholar
• Andrew EC, Curtis N, Coghlan B, Cranswick N, Gwee A. Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations. Br J Clin Pharmacol. 2018;84(5):1006–1012. doi:10.1111/bcp.13521
   PubMed Web of Science ®Google Scholar
• Butler KM, Rench MA, Baker CJ. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J. 1990;9(1):51–56. doi:10.1097/00006454-199001000-00012
   PubMed Web of Science ®Google Scholar
• Linder N, Klinger G, Shalit I, et al. Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. J Antimicrob Chemother. 2003;52(4):663–667. doi:10.1093/jac/dkg419
   PubMed Web of Science ®Google Scholar
• Le J, Adler-Shohet FC, Nguyen C, Lieberman JM. Nephrotoxicity associated with amphotericin B deoxycholate in neonates. Pediatr Infect Dis J. 2009;28(12):1061–1063. doi:10.1097/INF.0b013e3181af6201
   PubMed Web of Science ®Google Scholar
• Holler B, Omar SA, Farid MD, Patterson MJ. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants. Pediatrics. 2004;113(6):e608–16. doi:10.1542/peds.113.6.e608
   PubMed Web of Science ®Google Scholar
• Jacobs SE, Zagaliotis P, Walsh TJ. Novel antifungal agents in clinical trials. F1000Res. 2021;10:507. doi:10.12688/f1000research.28327.2
   PubMedGoogle Scholar
• Hornik CD, Bondi DS, Greene NM, Cober MP, John B. Review of fluconazole treatment and prophylaxis for invasive candidiasis in neonates. J Pediatr Pharmacol Ther. 2021;26(2):115–122. doi:10.5863/1551-6776-26.2.115
   PubMedGoogle Scholar
• Chen S, Sun KY, Feng XW, Ran X, Lama J, Ran YP. Efficacy and safety of itraconazole use in infants. World J Pediatr. 2016;12(4):399–407. doi:10.1007/s12519-016-0034-x
   PubMed Web of Science ®Google Scholar
• Mondal RK, Singhi SC, Chakrabarti A, J M. Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study. Pediatr Crit Care Med. 2004;5(6):561–565. doi:10.1097/01.Pcc.0000144712.29127.81
   PubMedGoogle Scholar
• Zimmermann T, Yeates RA, Laufen H, Pfaff G, Wildfeuer A. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Eur J Clin Pharmacol. 1994;46(2):147–150. doi:10.1007/bf00199879
   PubMed Web of Science ®Google Scholar
• Watt K, Manzoni P, Cohen-Wolkowiez M, et al. Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole. Curr Drug Metab. 2013;14(2):193–202.
   PubMed Web of Science ®Google Scholar
• Shima H, Miharu M, Osumi T, Takahashi T, Shimada H. Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age. Pediatr Blood Cancer. 2010;54(7):1050–1052. doi:10.1002/pbc.22451
   PubMed Web of Science ®Google Scholar
• Roberts JK, Stockmann C, Constance JE, et al. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. Clin Pharmacokinet. 2014;53(7):581–610. doi:10.1007/s40262-014-0147-0
   PubMed Web of Science ®Google Scholar
• Frankenbusch K, Eifinger F, Kribs A, Rengelshauseu J, Roth B. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight. J Perinatol. 2006;26(8):511–514. doi:10.1038/sj.jp.7211532
   PubMed Web of Science ®Google Scholar
• Muldrew KM, Maples HD, Stowe CD, Jacobs RF. Intravenous voriconazole therapy in a preterm infant. Pharmacotherapy. 2005;25(6):893–898. doi:10.1592/phco.2005.25.6.893
   PubMed Web of Science ®Google Scholar
• Krishnan T, Rishi P. Management of a case of Candida endogenous endophthalmitis in a neonate. Ocul Immunol Inflamm. 2014;22(1):77–78. doi:10.3109/09273948.2013.791923
   PubMed Web of Science ®Google Scholar
• Turner RB, Martello JL, Malhotra A. Worsening renal function in patients with baseline renal impairment treated with intravenous voriconazole: a systematic review. Int J Antimicrob Agents. 2015;46(4):362–366. doi:10.1016/j.ijantimicag.2015.05.023
   PubMed Web of Science ®Google Scholar
• Stemler J, Mellinghoff SC, Khodamoradi Y, et al. Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). J Antimicrob Chemother. 2023;13. doi:10.1093/jac/dkad143
   Google Scholar
• Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother. 2014;69(5):1162–1176. doi:10.1093/jac/dkt508
   PubMed Web of Science ®Google Scholar
• Treviño-Rangel RJ, González GM, Montoya AM, Rojas OC, Elizondo-Zertuche M, Álvarez-Villalobos NA. Recent antifungal pipeline developments against Candida auris: a systematic review. J Fungi. 2022;8(11):1144. doi:10.3390/jof8111144
   Web of Science ®Google Scholar
• Wiederhold NP. Pharmacodynamics, mechanisms of action and resistance, and spectrum of activity of new antifungal agents. J Fungi. 2022;8(8):857. doi:10.3390/jof8080857
   Web of Science ®Google Scholar
• Lyman M, Forsberg K, Reuben J, et al. Notes from the field: transmission of pan-resistant and echinocandin-resistant candida auris in health care facilities - Texas and the district of Columbia, January-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(29):1022–1023. doi:10.15585/mmwr.mm7029a2
   PubMed Web of Science ®Google Scholar
• Szekely J, Rakchang W, Rattanaphan P, Kositpantawong N. Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak. Epidemiol Infect. 2023;151:e146. doi:10.1017/s0950268823001346
   PubMed Web of Science ®Google Scholar
• Hope WW, Seibel NL, Schwartz CL, et al. Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. Antimicrob Agents Chemother. 2007;51(10):3714–3719. doi:10.1128/aac.00398-07
   PubMed Web of Science ®Google Scholar
• Hope WW, Mickiene D, Petraitis V, et al. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. J Infect Dis. 2008;197(1):163–171. doi:10.1086/524063
   PubMed Web of Science ®Google Scholar
• Benjamin DK, Kaufman DA, Hope WW, et al. A Phase 3 study of Micafungin versus Amphotericin B deoxycholate in infants with invasive candidiasis. Pediatr Infect Dis J. 2018;37(10):992–998. doi:10.1097/inf.0000000000001996
   PubMed Web of Science ®Google Scholar
• Queiroz-Telles F, Berezin E, Leverger G, et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J. 2008;27(9):820–826. doi:10.1097/INF.0b013e31817275e6
   PubMed Web of Science ®Google Scholar
• Arrieta AC, Maddison P, Groll AH. Safety of micafungin in pediatric clinical trials. Pediatr Infect Dis J. 2011;30(6):e97–e102. doi:10.1097/INF.0b013e3182127eaf
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Adamson PC, Seibel NL, et al. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother. 2005;49(11):4536–4545. doi:10.1128/aac.49.11.4536-4545.2005
   PubMed Web of Science ®Google Scholar
• Cohen-Wolkowiez M, Benjamin DK, Piper L, et al. Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates. Clin Pharmacol Ther. 2011;89(5):702–707. doi:10.1038/clpt.2011.26
   PubMed Web of Science ®Google Scholar
• Roilides E, Carlesse F, Tawadrous M, et al. Safety, efficacy and pharmacokinetics of anidulafungin in patients 1 month to <2 years of age with invasive candidiasis, including candidemia. Pediatr Infect Dis J. 2020;39(4):305–309. doi:10.1097/inf.0000000000002568
   PubMed Web of Science ®Google Scholar
• Ham YY, Lewis JS, Thompson GR. Rezafungin: a novel antifungal for the treatment of invasive candidiasis. Future Microbiol. 2021;16(1):27–36. doi:10.2217/fmb-2020-0217
   PubMed Web of Science ®Google Scholar
• Thompson GR, Soriano A, Cornely OA, et al. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Lancet. 2023;401(10370):49–59. doi:10.1016/s0140-6736(22)02324-8
   PubMed Web of Science ®Google Scholar
• Syed YY. Rezafungin: first approval. Drugs. 2023;83(9):833–840. doi:10.1007/s40265-023-01891-8
   PubMed Web of Science ®Google Scholar
• Sigera LSM, Denning DW. Flucytosine and its clinical usage. Ther Adv Infect Dis. 2023;10:20499361231161387. doi:10.1177/20499361231161387
   Web of Science ®Google Scholar
• Robati Anaraki M, Nouri-Vaskeh M, Abdoli Oskoei S. Fluconazole prophylaxis against invasive candidiasis in very low and extremely low birth weight preterm neonates: a systematic review and meta-analysis. Clin Exp Pediatr. 2021;64(4):172–179. doi:10.3345/cep.2019.01431
   PubMedGoogle Scholar
• Benjamin DK, Hudak ML, Duara S, et al. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA. 2014;311(17):1742–1749. doi:10.1001/jama.2014.2624
   PubMed Web of Science ®Google Scholar
• Lee J, Kim HS, Shin SH, et al. Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study. BMC Pediatr. 2016;16(1):67. doi:10.1186/s12887-016-0605-y
   PubMedGoogle Scholar
• Autmizguine J, Smith PB, Prather K, et al. Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants. J Antimicrob Chemother. 2018;73(12):3482–3487. doi:10.1093/jac/dky353
   PubMed Web of Science ®Google Scholar
• Sims ME, Yoo Y, You H, Salminen C, Walther FJ. Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. Am J Perinatol. 1988;5(1):33–36. doi:10.1055/s-2007-999649
   PubMed Web of Science ®Google Scholar
• Rundjan L, Wahyuningsih R, Oeswadi CA, Marsogi M, Purnamasari A. Oral nystatin prophylaxis to prevent systemic fungal infection in very low birth weight preterm infants: a randomized controlled trial. BMC Pediatr. 2020;20(1):170. doi:10.1186/s12887-020-02074-0
   PubMed Web of Science ®Google Scholar
• Mersal A, Alzahrani I, Azzouz M, et al. Oral nystatin versus intravenous fluconazole as neonatal antifungal prophylaxis: non-inferiority trial. J Clin Neonatol. 2013;2(2):88–92. doi:10.4103/2249-4847.116408
   PubMedGoogle Scholar
• Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA. 2009;302(13):1421–1428. doi:10.1001/jama.2009.1403
   PubMed Web of Science ®Google Scholar
• Berrington JE, McGuire W, Embleton ND. ELFIN, the United Kingdom preterm lactoferrin trial: interpretation and future questions (1). Biochem Cell Biol. 2021;99(1):1–6. doi:10.1139/bcb-2020-0073
   PubMedGoogle Scholar
• Laforest-Lapointe I, Arrieta MC. Patterns of early-life gut microbial colonization during human immune development: an ecological perspective. Front Immunol. 2017;8:788. doi:10.3389/fimmu.2017.00788
   PubMed Web of Science ®Google Scholar
• Samara J, Moossavi S, Alshaikh B, et al. Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host Microbe. 2022;30(5):696–711.e5. doi:10.1016/j.chom.2022.04.005
   PubMed Web of Science ®Google Scholar
• AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;4:Cd005496. doi:10.1002/14651858.CD005496.pub4
   PubMed Web of Science ®Google Scholar
• Dermyshi E, Wang Y, Yan C, et al. The “Golden Age” of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology. 2017;112(1):9–23. doi:10.1159/000454668
   PubMed Web of Science ®Google Scholar
• Poindexter B, Cummings J, Hand I. Use of probiotics in preterm infants. Pediatrics. 2021;147(6). doi:10.1542/peds.2021-051485
   Web of Science ®Google Scholar
• Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis. 2016;22(9):1664–1666. doi:10.3201/eid2209.160033
   PubMed Web of Science ®Google Scholar
• Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis. 2015;60(6):924–927. doi:10.1093/cid/ciu946
   PubMed Web of Science ®Google Scholar
• Roy U, Jessani LG, Rudramurthy SM, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses. 2017;60(6):375–380. doi:10.1111/myc.12604
   PubMed Web of Science ®Google Scholar
• Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255–259. doi:10.1016/j.clnesp.2020.05.020
   PubMed Web of Science ®Google Scholar